臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 71-95 of 1656 (67 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-19T00:20:41Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; CHIUN HSU; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2022-08-19T00:20:40Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	CHIUN HSU; Wang M.-J.; Cheng A.-L.; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:20:38Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Liu T.-H.; Shao Y.-Y.; Lu L.-C.
臺大學術典藏	2022-08-19T00:20:36Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; CHIUN HSU; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:20:34Z	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO	Douillard J.-Y.; Yoshino T.; Yen Y.; Hsu C.-H.; Tabernero J.; Shen Y.-C.; CHIUN HSU; Chen S.-C.; Huang Y.-H.; Yen C.-J.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Pentheroudakis G.; Cheng A.-L.; Chen L.-T.; Martinelli E.
臺大學術典藏	2022-08-19T00:20:33Z	Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study	Tebbutt N.; Strickler J.; Stein S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Dev A.; Davis S.L.; Chung H.C.; Chen J.-S.; Chao Y.; Bendell J.; Bang Y.-J.; Lee K.-H.; He A.R.; Wang Y.; Liu B.; Abdullah H.; Hack S.P.; Spahn J.; Lee M.S.; Ryoo B.-Y.; Hsu C.-H.; Numata K.; Stein S.; Verret W.
臺大學術典藏	2022-08-19T00:20:30Z	Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma	Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; CHIUN HSU; Hsu C.-H.; Yang M.-H.; Chao Y.
臺大學術典藏	2022-08-19T00:20:28Z	The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma	Hung Y.-P.; CHIUN HSU; Lee J.-M.; Chao Y.; Shao Y.-Y.; Hsu C.-H.; Yang M.-H.
臺大學術典藏	2022-08-19T00:20:28Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	Sun N.-Y.; CHIUN HSU; Cheng A.-L.; Shao Y.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:27Z	Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials	Lin Z.-Z.; Hsu C.-H.; Liang P.-C.; Chen B.-B.; Shao Y.-Y.; CHIUN HSU; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2022-08-19T00:20:27Z	Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma	Lin Z.-Z.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Liang P.-C.
臺大學術典藏	2022-08-19T00:20:26Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	CHIUN HSU; Shao Y.-Y.; Chen C.-H.; Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.-H.; Lin Z.-Z.; Lu L.-C.; Liu T.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:25Z	Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma	Liang P.-C.; Liu T.-H.; Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chen B.-B.; Shih T.T.-F.; Shen Y.-C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:24Z	AXL and MET in Hepatocellular Carcinoma: A Systematic Literature review	Huang Y.-H.; CHIUN HSU; Hsu C.-H.; Lin S.-M.
臺大學術典藏	2022-08-12T06:29:09Z	A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers	Yeh K.-H.; Cheng A.-L.; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; KING-JEN CHANG; Lee P.-H.; Chen Y.-C.
臺大學術典藏	2022-08-12T06:28:26Z	P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection	Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; KING-JEN CHANG
臺大學術典藏	2022-08-12T06:28:23Z	High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection	Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; KING-JEN CHANG
臺大學術典藏	2022-08-12T06:28:04Z	Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin b	Huang T.-C.; Chang H.-Y.; Hsu C.-H.; Kuo W.-H.; KING-JEN CHANG; Juan H.-F.
臺大學術典藏	2022-08-12T06:27:44Z	Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change	Tyan S.-W.; Hsu C.-H.; Peng K.-L.; Chen C.-C.; Kuo W.-H.; Lee E.Y.-H.P.; Shew J.-Y.; KING-JEN CHANG; Juan L.-J.; Lee W.-H.
臺大學術典藏	2022-08-09T03:50:41Z	Self assembled gold and silver nanoparticulates on silicon nanotips as surface enhanced Raman active substrates	Chattopadhyay S.; Lo H.C.; Chen K.H.; Hsu C.H.; Chen L.C.; Chattopadhyay S.; Lo H.C.; Chen K.H.; Hsu C.H.; Chen L.C.; LI-CHYONG CHEN
臺大學術典藏	2022-08-09T03:50:37Z	Generally applicable self-masked dry etching technique for nanotip array fabrication	Hsu C.-H.; Lo H.-C.; Chen C.-F.; Wu C.T.; Hwang J.-S.; Das D.; Tsai J.; Chen L.-C.; Chen K.-H.; Hsu C.-H.; Lo H.-C.; Chen C.-F.; Wu C.T.; Hwang J.-S.; Das D.; Tsai J.; Chen L.-C.; Chen K.-H.; LI-CHYONG CHEN
臺大學術典藏	2022-07-28T07:28:09Z	Mitochondrial DNA methylation profiling of the human prefrontal cortex and nucleus accumbens: correlations with aging and drug use	Huang C.-H.; Chang M.-C.; Lai Y.-C.; Lin C.-Y.; Hsu C.-H.; Tseng B.-Y.; Hsiao C.K.; Lu T.-P.; Yu S.-L.; SUNG-TSANG HSIEH; Chen W.J.
臺大學術典藏	2022-07-26T08:55:57Z	Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma	Shao Y.-Y.; Kuo H.-Y.; YUNG-MING JENG; Wu Y.-M.; Wang H.-P.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2022-07-12T01:43:03Z	The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: A systemic review and meta-analysis	Chang S.-C.; Hsu C.-H.; Hsu C.-K.; Yang S.S.-D.; SHANG-JEN CHANG
臺大學術典藏	2022-06-27T07:06:22Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.

Showing items 71-95 of 1656 (67 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2823024
	???header.visitor??? : 30227244 ???header.onlineuser??? : 819 ???header.sponsordeclaration???